In type 2 diabetes, rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control (Q44745053)
Jump to navigation
Jump to search
scientific article published in February 2004
Language | Label | Description | Also known as |
---|---|---|---|
English | In type 2 diabetes, rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control |
scientific article published in February 2004 |
Statements
1 reference
In type 2 diabetes, rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control (English)
1 reference
Markolf Hanefeld
1 reference
Frank Pistrosch
1 reference
Jens Passauer
1 reference
Sabine Fischer
1 reference
Katja Fuecker
1 reference
Peter Gross
1 reference
1 February 2004
1 reference
1 reference
27
1 reference
2
1 reference
484-490
1 reference
Identifiers
1 reference
1 reference